These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24673452)

  • 1. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
    Kong Q; Li P; Tian Q; Ha MW
    Genet Test Mol Biomarkers; 2014 May; 18(5):357-65. PubMed ID: 24673452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
    Tang T; Song X; Yang Z; Huang L; Wang W; Tan H
    Tumour Biol; 2014 Nov; 35(11):11353-7. PubMed ID: 25119589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MDM2 T309G polymorphism and risk of lung cancer: an updated meta-analysis of 10,186 cases and 14,155 controls.
    Tian X; Wang B; Guo J; Liu X; Zhang T; Liang C; Zhou N; Hou X; Ma Y; Yu H; Chen L; Ren Z; Fan K; Tian Q
    Panminerva Med; 2016 Dec; 58(4):341-348. PubMed ID: 27171940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T309G murine double minute 2 gene polymorphism is an independent prognostic factor for patients with renal cell carcinoma.
    de Martino M; Taus C; Wessely IS; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
    DNA Cell Biol; 2015 Feb; 34(2):107-12. PubMed ID: 25415135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
    Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
    Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis.
    Luan L; Wang H; Zhao B; Wang F; Shi J; Xu X
    Pathol Res Pract; 2019 Sep; 215(9):152538. PubMed ID: 31326197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk.
    Song B; Duan ZY; Zhong YH; Lei N; Yang YQ; Luo KY
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6649-51. PubMed ID: 24377582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis.
    Yan YL; Han F; Tan WM; Wu CP; Qin X
    Asian Pac J Cancer Prev; 2014; 15(16):6767-72. PubMed ID: 25169523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: meta-analysis of 15 studies.
    Shen W; Hu P; Cao JQ; Liu XX; Shao JH
    J Int Med Res; 2014 Oct; 42(5):1065-76. PubMed ID: 25070969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.
    Liu GY; Jiang DK; Shen SQ; Yu L
    Arch Med Res; 2011 Feb; 42(2):149-55. PubMed ID: 21565629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
    Zhuo W; Zhang L; Zhu B; Ling J; Chen Z
    PLoS One; 2012; 7(7):e41546. PubMed ID: 22844496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML; Xu YX; Qian J; Wang FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.
    Han JY; Lee GK; Jang DH; Lee SY; Lee JS
    Cancer; 2008 Aug; 113(4):799-807. PubMed ID: 18618574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between MTP -493G>T polymorphism and non-alcoholic fatty liver disease risk: a meta-analysis.
    Li L; Wang SJ; Shi K; Chen D; Jia H; Zhu J
    Genet Mol Res; 2014 Dec; 13(4):10150-61. PubMed ID: 25501226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of ANP genetic polymorphisms and serum levels with ischemic stroke risk: a meta-analysis.
    Xing DG; Zhang DY; Wang ZF; Ding DL; Wang J; Wang YJ
    Genet Test Mol Biomarkers; 2014 May; 18(5):349-56. PubMed ID: 24654911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibility.
    Chen B; Xiong MM; Meng XL
    Dis Esophagus; 2015; 28(6):593-601. PubMed ID: 24844868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
    Xue Z; Zhu X; Teng Y
    Med Sci Monit; 2016 Sep; 22():3186-90. PubMed ID: 27604213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk.
    Liu G; Wheatley-Price P; Zhou W; Park S; Heist RS; Asomaning K; Wain JC; Lynch TJ; Su L; Christiani DC
    Int J Cancer; 2008 Feb; 122(4):915-8. PubMed ID: 17957785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in the IL-18 gene and ulcerative colitis risk: a meta-analysis.
    Wang Y; Tong J; Chang B; Wang BF; Zhang D; Wang BY
    DNA Cell Biol; 2014 Jul; 33(7):438-47. PubMed ID: 24621393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of associations between the MDM2-T309G polymorphism and prostate cancer risk.
    Chen T; Yi SH; Liu XY; Liu ZG
    Asian Pac J Cancer Prev; 2012; 13(9):4327-30. PubMed ID: 23167337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.